BRIDGEBIO PHARMA INC's ticker is and the CUSIP is 10806XAB8. A total of 41 filers reported holding BRIDGEBIO PHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,408,804 | +62.1% | 16,880,000 | +31.1% | 0.00% | 0.0% |
| Q2 2023 | $10,121,267 | +18.3% | 12,880,000 | +11.7% | 0.00% | – |
| Q1 2023 | $8,554,851 | -31.3% | 11,530,000 | -57.4% | 0.00% | – |
| Q4 2022 | $12,458,274 | +55.8% | 27,060,000 | +100.0% | 0.00% | -100.0% |
| Q3 2022 | $7,997,000 | +25.1% | 13,530,000 | +17.3% | 0.00% | – |
| Q2 2022 | $6,390,000 | -15.0% | 11,530,000 | -8.7% | 0.00% | – |
| Q1 2022 | $7,519,000 | -37.3% | 12,630,000 | -22.1% | 0.00% | -100.0% |
| Q4 2021 | $11,985,000 | -47.8% | 16,205,000 | -2.4% | 0.00% | 0.0% |
| Q3 2021 | $22,954,000 | -5.8% | 16,605,000 | +12.2% | 0.00% | 0.0% |
| Q2 2021 | $24,375,000 | +28.6% | 14,805,000 | +29.0% | 0.00% | 0.0% |
| Q1 2021 | $18,948,000 | – | 11,480,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARISTEIA CAPITAL, L.L.C. | 100,224,000 | $60,134,000 | 1.09% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 80,000,000 | $47,402,000 | 1.06% |
| Affinity Asset Advisors, LLC | 7,500,000 | $4,380,000 | 0.70% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 49,229,000 | $28,932,000 | 0.67% |
| Context Capital Management, LLC | 16,489 | $9,850,000 | 0.64% |
| CONTRARIAN CAPITAL MANAGEMENT, L.L.C. | 6,000,000 | $3,444,000 | 0.46% |
| TFG Asset Management GP Ltd | 15,000,000 | $8,942,000 | 0.41% |
| WOLVERINE ASSET MANAGEMENT LLC | 58,069,000 | $33,968,000 | 0.33% |
| SILVERBACK ASSET MANAGEMENT LLC | 4,000,000 | $2,333,000 | 0.32% |
| Ionic Capital Management LLC | 4,500,000 | $2,676,000 | 0.30% |